The federal government’s use of artificial intelligence to conduct compliance audits is drawing sharp legal scrutiny from healthcare organisations and policy experts across the United States.
HHS launched its AERO initiative, which stands for Audit Enforcement and Risk Oversight, on May 21, 2026, raising immediate concerns among federally funded entities.
The programme uses artificial intelligence to re-score at least five years of Single Audit Act compliance data for any entity receiving more than one million dollars annually in federal awards.
Critics argue the initiative bypasses standard legal safeguards by deploying retroactive AI-driven findings against hospitals and other grantees without prior notice or opportunity to challenge the methodology.
One of the central legal arguments against AERO is that HHS announced the programme via press release and letters to state governors rather than through formal notice-and-comment rulemaking under the Administrative Procedure Act.
That procedural shortcut, lawyers argue, denied regulated entities any opportunity to review the AI’s methodology or contest its assumptions before the system was applied to years of historical compliance data.
The AI model at the heart of AERO has been described as a “black box,” meaning grantees are informed of what the algorithm concluded but receive no explanation of how or why those conclusions were reached.
Under the APA’s arbitrary and capricious standard, an AI finding alone is unlikely to constitute what courts would recognise as a reasoned agency determination, since judges have consistently required agencies to articulate a rational, non-algorithmic basis for enforcement actions.
The practical consequences of receiving an AERO finding are severe and immediate, potentially triggering payment withholding, cost disallowances, award suspensions, and formal debarment proceedings.
For hospitals and healthcare networks that depend heavily on federal funding, such outcomes carry both serious financial damage and lasting reputational harm within the broader healthcare sector.
Legal advisers working with affected organisations are urging entities to file Freedom of Information Act requests before responding to any AERO correspondence from HHS.
Those FOIA requests should specifically seek the AI’s underlying methodology, any validation studies conducted before deployment, and records showing federal approval of the system.
Building a thorough administrative record early in the process is considered essential to exposing weaknesses in enforcement actions and mounting a credible legal challenge against AERO findings.
The initiative represents a broader and accelerating trend of federal agencies incorporating algorithmic tools into enforcement decisions that carry significant consequences for private and public sector organisations alike.
Whether courts will ultimately accept or reject AI-generated findings as sufficient grounds for enforcement actions under existing administrative law standards remains an open and closely watched legal question for 2026.